The double-edged sword of autophagy modulation in cancer

E White, RS DiPaola - Clinical cancer research, 2009 - AACR
E White, RS DiPaola
Clinical cancer research, 2009AACR
Macroautophagy (autophagy) is a lysosomal degradation pathway for the breakdown of
intracellular proteins and organelles. Although constitutive autophagy is a homeostatic
mechanism for intracellular recycling and metabolic regulation, autophagy is also stress
responsive, in which it is important for the removal of damaged proteins and organelles.
Autophagy thereby confers stress tolerance, limits damage, and sustains viability under
adverse conditions. Autophagy is a tumor-suppression mechanism, yet it enables tumor cell …
Abstract
Macroautophagy (autophagy) is a lysosomal degradation pathway for the breakdown of intracellular proteins and organelles. Although constitutive autophagy is a homeostatic mechanism for intracellular recycling and metabolic regulation, autophagy is also stress responsive, in which it is important for the removal of damaged proteins and organelles. Autophagy thereby confers stress tolerance, limits damage, and sustains viability under adverse conditions. Autophagy is a tumor-suppression mechanism, yet it enables tumor cell survival in stress. Reconciling how loss of a prosurvival function can promote tumorigenesis, emerging evidence suggests that preservation of cellular fitness by autophagy may be key to tumor suppression. As autophagy is such a fundamental process, establishing how the functional status of autophagy influences tumorigenesis and treatment response is important. This is especially critical as many current cancer therapeutics activate autophagy. Therefore, efforts to understand and modulate the autophagy pathway will provide new approaches to cancer therapy and prevention. (Clin Cancer Res 2009;15(17):5308–16)
AACR